logo
Trump Media seeks SEC approval for bitcoin and ethereum ETF

Trump Media seeks SEC approval for bitcoin and ethereum ETF

CNA19 hours ago

Trump Media & Technology Group is seeking to launch an exchange-traded fund that will invest in both bitcoin and ethereum, the two largest cryptocurrencies, according to a filing with the U.S. Securities and Exchange Commission on Monday.
This marks the second cryptocurrency ETF filing from the social media company associated with President Donald Trump in less than two weeks. If approved, the Truth Social Bitcoin ETF and the Truth Social Bitcoin & Ethereum ETF would join a crowded and competitive market already dominated by a handful of established asset managers such as BlackRock, whose iShares Bitcoin ETF has $72.5 billion in assets.
"It will be a challenge for any new entrant in this market," said Bryan Armour, ETF analyst at Morningstar. "The only way to stand out will be through fees or brand."
The filing for the new bitcoin and ethereum ETF does not disclose proposed fees, and Trump Media has yet to reveal fees for the bitcoin ETF. Similar products have fees of 0.12 per cent.
Trump Media representatives did not immediately respond to a request for comment.
Armour noted that the latest filing spells out a specific allocation ratio between bitcoin and ethereum. The issuer, Yorkville America Digital, said it initially anticipates holding three bitcoins for every ethereum token in the ETF.
"There is little that is different about this new venture other than the way it could be marketed," said Sui Chung, CEO and chairman of CF Benchmarks. "Given Truth Social's involvement, it may very well be that (these) are marketed directly to individual investors and that this ends up getting attention from those investors in the same way that people who love their iPhones buy Apple stock."

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Nasdaq-listed herbal medicine stock with no sales rallies 64,000%
Nasdaq-listed herbal medicine stock with no sales rallies 64,000%

Straits Times

timean hour ago

  • Straits Times

Nasdaq-listed herbal medicine stock with no sales rallies 64,000%

The unbelievable rally has transformed Regencell Bioscience Holdings, a penny stock as recently as April, to one worth more than US$20 billion (S$25.6 billion) in market value. PHOTO: ST FILE NEW YORK - A Nasdaq-listed stock focused on herbal medicine has spiked by more than 64,000 per cent so far in 2025 and yet, the company itself has made zero revenue – much less turned a profit. The unbelievable rally has transformed Regencell Bioscience Holdings, a penny stock as recently as April, to one worth more than US$20 billion (S$25.6 billion) in market value. A year ago, the stock had a market capitalisation of just US$53 million. This is despite the company having a net loss of US$4.4 million for its fiscal year that ended June 2024, a 28 per cent decrease from the previous year. Earlier in June the company said its board approved a 38-for-1 stock split. When the split took effect on June 16, shares soared as much as 434 per cent – their biggest one-day jump ever – to a record high, triggering more than 10 volatility halts. Shares of the company have been on a bizarre, 640-fold tear in 2025, with little to no news from the firm. The Hong Kong-based firm, which debuted on the Nasdaq Capital Market in 2021, is in the research and development stage and has not generated any revenue since inception, according to its most-recent annual filing with the US Securities and Exchange Commission (SEC). A representative for Regencell didn't immediately respond to a Bloomberg News request for comment. Incorporated in the Cayman Islands, the firm aims to treat neurological disorders like ADHD and autism spectrum disorder through traditional herb-based medicines, according to its website. Its traditional Chinese medicine (TCM) formula, which forms the basis of its product candidates, 'contains only natural ingredients without any synthetic components.' 'We have not generated revenue from any TCM formulae candidates or applied for any regulatory approvals, nor have distribution capabilities or experience or any granted patents or pending patent applications and may never be profitable,' the company said in an October filing. The company also made its foray into treatments for Covid-19, conducting trials in 2022 for an 'holistic approach' with its experimental therapy. Regencell said data from a 2022 trial showed the treatment was effective in reducing and eliminating Covid symptoms within six days, although the results were yet to be peer-reviewed. The firm has funded its operations so far, primarily from shareholder loans and proceeds from its initial public offering, the SEC filing showed. It said its gross proceeds from its IPO were US$21.85 million, with additional net proceeds of US$2.85 million from the issue of the over allotment shares and exercise of 325,000 shares. One potential reason for the outsized swings in Regencell shares: its tiny float. Of its nearly 500 million outstanding shares, only about 30 million are available to be traded. That equates to roughly 6 per cent of shares, compared to Apple – which has about 98 per cent available – and Tesla's 87 per cent. Insiders own the remaining Regencell shares, with chief executive officer Yat-Gai Au's ownership accounting for 86 per cent, according to holding data compiled by Bloomberg. BLOOMBERG Join ST's Telegram channel and get the latest breaking news delivered to you.

Family offices look to raise allocations to non-US, developed markets equities: BlackRock survey
Family offices look to raise allocations to non-US, developed markets equities: BlackRock survey

Business Times

time2 hours ago

  • Business Times

Family offices look to raise allocations to non-US, developed markets equities: BlackRock survey

[SINGAPORE] Family offices are raising their portfolio allocations for non-US developed market equities as tariff tensions and concerns about a US economic slowdown are prompting many to diversify, a BlackRock survey has found. This comes as US shares have had a volatile year marked by the Trump administration's on-and-off tariff shifts, with the S&P 500 underperforming indices in Europe and Asia. In the year to date, the S&P 500 has inched up only 2.6 per cent compared to other global markets: Europe's Stoxx 600 rose 8.3 per cent, Hong Kong's Hang Seng Index jumped 19.9 per cent, and South Korea's Kospi has soared about 22 per cent. With an upheaval in global markets set off by 'Liberation Day' tariffs and the possibility of the US economy slowing down, family offices are rethinking their investment portfolios, which tend to have significant exposure to US equities, bonds, and the greenback. Up to 64 per cent of family offices are looking to increase portfolio diversification and 84 per cent see the challenging geopolitical landscape as an increasingly critical factor that weighs on their investment decisions, leading to a reassessment of how they generate returns and manage risks. With the drive towards diversification, 59 per cent seek to raise their allocations to non-US developed market equities, said the report, which surveyed 175 single-family offices that collectively oversee assets worth more than US$300 billion. Many family offices are also looking to private markets for diversification and higher returns, the report added. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Alternative assets, which make up 42 per cent of family office portfolios, appear set to remain a portfolio cornerstone, despite rising concerns about fees. The appetite for infrastructure investments is also growing, with 75 per cent of survey respondents positive on the asset class' prospects. Liquid and illiquid alternatives, cash, and crypto, are also set to be beneficiaries from family offices' push for diversification and downside mitigation. Private credit becomes core allocation Sentiment on private credit is bullish as close to a third or 32 per cent of family offices plan to raise allocations to the asset class between 2025 to 2026 – the highest figures among alternative asset classes covered by the survey. It is becoming a core allocation in portfolio of many family offices and occupies 15 to 30 per cent of total AUM for the portfolios of some respondents, the report said. 'The asset class has attracted fresh capital and allocations previously earmarked for public debt, private equity, and venture capital,' it said. When it comes to selecting particular strategies within private credit, respondents prefer special situations and direct lending – as both categories are viewed as offering equity-like returns with superior structural protection. While some see opportunities in potential volatility some respondents are worried about crowding in the private credit space or the performance of the asset class in a recession during a credit downcycle. Infrastructure: resilient, hedge against inflation . Favoured for its perceived resilience and inflation mitigation abilities, 'infrastructure's role as a portfolio diversifier that can provide inflation-linked yield is a compelling combination for family offices', the report said. Infrastructure's ability to generate stable cash flows and its alignment with long-term secular growth themes, such as the energy transition and digital connectivity, make it appealing Sentiment on infrastructure is bullish as three in ten family offices plan to raise allocations to infrastructure investments between 2025 and 2026. This makes the asset class the second most popular of all alternative assets surveyed, a runner-up to private credit's 32 per cent.

Amazon announces four-day Prime Day discount event
Amazon announces four-day Prime Day discount event

CNA

time4 hours ago

  • CNA

Amazon announces four-day Prime Day discount event

NEW YORK : annual Prime Day sales event is scheduled for July 8 through July 11, expanding to four days from two days compared to last year, the company announced on Tuesday. "We're extending it to four days because our members have told us they just need more time to shop the deals," Jamil Ghani, Amazon vice president of worldwide prime, told Reuters. Amazon's expanding Prime Day comes as U.S. shoppers and retailers face uncertainty on how tariffs will impact prices and product availability, said Rob Garf, senior vice president of strategy and insights at retail marketing firm Cordial. U.S. shoppers spent $14.2 billion, up 11 per cent year-over-year, during Amazon's July 2024 Prime Day event, according to Adobe Analytics. The e-commerce giant often faces competing sales events from Walmart, Target and, now, ByteDance's TikTok Shop, which are trying to lure shoppers into spending early on back-to-school and back-to-college merchandise including personal electronics, apparel and home goods. The online retailer wants to entice younger shoppers to sign up for its subscription service Prime, by offering discounted memberships for people between the ages of 18 and 24 and other perks. Prime subscriptions typically cost $14.99 per month or $139 per year.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store